Alprazolam-induced dyscontrol in borderline personality disorder.
The authors report a significant increase in dyscontrol in patients with borderline personality disorder who were taking alprazolam during a double-blind, placebo-controlled crossover study. They suggest that caution be used in prescribing alprazolam to patients with similar histories.
Gardner
D L
DL
Cowdry
R W
RW
D000328:Adult; D000525:Alprazolam; D000553:Ambulatory Care; D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D001569:Benzodiazepines / Q000009:adverse effects* / Q000627:therapeutic use; D001883:Borderline Personality Disorder / Q000188:drug therapy* / Q000523:psychology; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006801:Humans; D007175:Impulsive Behavior / Q000139:chemically induced; D010554:Personality Disorders / Q000188:drug therapy*; D010919:Placebos; D012652:Self Mutilation / Q000139:chemically induced; D013406:Suicide, Attempted / Q000523:psychology; D014754:Violence
D014151:Anti-Anxiety Agents; D010919:Placebos; D001569:Benzodiazepines; D000525:Alprazolam